1
|
Yogi A, Grosso CA. Editorial: Methods and applications in Alzheimer's disease and related dementias. Front Aging Neurosci 2022; 14:1083257. [DOI: 10.3389/fnagi.2022.1083257] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Accepted: 11/09/2022] [Indexed: 11/30/2022] Open
|
2
|
Alata W, Yogi A, Brunette E, Delaney CE, Faassen H, Hussack G, Iqbal U, Kemmerich K, Haqqani AS, Moreno MJ, Stanimirovic DB. Targeting insulin‐like growth factor‐1 receptor (IGF1R) for brain delivery of biologics. FASEB J 2022; 36:e22208. [DOI: 10.1096/fj.202101644r] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2021] [Revised: 01/13/2022] [Accepted: 02/01/2022] [Indexed: 12/25/2022]
Affiliation(s)
- Wael Alata
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Alvaro Yogi
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Eric Brunette
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Christie E. Delaney
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Henk Faassen
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Greg Hussack
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Umar Iqbal
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Kristin Kemmerich
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Arsalan S. Haqqani
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Maria J. Moreno
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| | - Danica B. Stanimirovic
- Human Health Therapeutics Research Centre National Research Council Canada Ottawa Ontario Canada
| |
Collapse
|
3
|
Yogi A, Rukhlova M, Charlebois C, Tian G, Stanimirovic DB, Moreno MJ. Differentiation of Adipose-Derived Stem Cells into Vascular Smooth Muscle Cells for Tissue Engineering Applications. Biomedicines 2021; 9:biomedicines9070797. [PMID: 34356861 PMCID: PMC8301460 DOI: 10.3390/biomedicines9070797] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2021] [Revised: 06/15/2021] [Accepted: 06/25/2021] [Indexed: 11/20/2022] Open
Abstract
Synthetic grafts have been developed for vascular bypass surgery, however, the risks of thrombosis and neointimal hyperplasia still limit their use. Tissue engineering with the use of adipose-derived stem cells (ASCs) has shown promise in addressing these limitations. Here we further characterized and optimized the ASC differentiation into smooth muscle cells (VSMCs) induced by TGF-β and BMP-4. TGF-β and BMP-4 induced a time-dependent expression of SMC markers in ASC. Shortening the differentiation period from 7 to 4 days did not impair the functional property of contraction in these cells. Stability of the process was demonstrated by switching cells to regular growth media for up to 14 days. The role of IGFBP7, a downstream effector of TGF-β, was also examined. Finally, topographic and surface patterning of a substrate is recognized as a powerful tool for regulating cell differentiation. Here we provide evidence that a non-woven PET structure does not affect the differentiation of ASC. Taken together, our results indicate that VSMCs differentiated from ASCs are a suitable candidate to populate a PET-based vascular scaffolds. By employing an autologous source of cells we provide a novel alternative to address major issues that reduces long-term patency of currently vascular grafts.
Collapse
Affiliation(s)
- Alvaro Yogi
- Human Health Therapeutics, National Research Council of Canada, 1200 Montreal Road, Ottawa, ON K1A0R6, Canada; (M.R.); (C.C.); (D.B.S.)
- Correspondence: (A.Y.); (M.J.M.); Tel.: +1-613-990-0891 (A.Y.); +1-613-990-0829 (M.J.M.)
| | - Marina Rukhlova
- Human Health Therapeutics, National Research Council of Canada, 1200 Montreal Road, Ottawa, ON K1A0R6, Canada; (M.R.); (C.C.); (D.B.S.)
| | - Claudie Charlebois
- Human Health Therapeutics, National Research Council of Canada, 1200 Montreal Road, Ottawa, ON K1A0R6, Canada; (M.R.); (C.C.); (D.B.S.)
| | - Ganghong Tian
- Medical Devices Research Centre, National Research Council of Canada, 435 Ellice Ave, Winnipeg, MB R3B 1Y6, Canada;
| | - Danica B. Stanimirovic
- Human Health Therapeutics, National Research Council of Canada, 1200 Montreal Road, Ottawa, ON K1A0R6, Canada; (M.R.); (C.C.); (D.B.S.)
| | - Maria J. Moreno
- Human Health Therapeutics, National Research Council of Canada, 1200 Montreal Road, Ottawa, ON K1A0R6, Canada; (M.R.); (C.C.); (D.B.S.)
- Correspondence: (A.Y.); (M.J.M.); Tel.: +1-613-990-0891 (A.Y.); +1-613-990-0829 (M.J.M.)
| |
Collapse
|
4
|
Thom G, Burrell M, Haqqani AS, Yogi A, Lessard E, Brunette E, Delaney C, Baumann E, Callaghan D, Rodrigo N, Webster CI, Stanimirovic DB. Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26. Mol Pharm 2018; 15:1420-1431. [PMID: 29485883 DOI: 10.1021/acs.molpharmaceut.7b00937] [Citation(s) in RCA: 40] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The blood-brain barrier (BBB) is a formidable obstacle for brain delivery of therapeutic antibodies. However, antibodies against the transferrin receptor (TfR), enriched in brain endothelial cells, have been developed as delivery carriers of therapeutic cargoes into the brain via a receptor-mediated transcytosis pathway. In vitro and in vivo studies demonstrated that either a low-affinity or monovalent binding of these antibodies to the TfR improves their release on the abluminal side of the BBB and target engagement in brain parenchyma. However, these studies have been performed with mouse-selective TfR antibodies that recognize different TfR epitopes and have varied binding characteristics. In this study, we evaluated serum pharmacokinetics and brain and CSF exposure of the rat TfR-binding antibody OX26 affinity variants, having KDs of 5 nM, 76 nM, 108 nM, and 174 nM, all binding the same epitope in bivalent format. Pharmacodynamic responses were tested in the Hargreaves chronic pain model after conjugation of OX26 affinity variants with the analgesic and antiepileptic peptide, galanin. OX26 variants with affinities of 76 nM and 108 nM showed enhanced brain and cerebrospinal fluid (CSF) exposure and higher potency in the Hargreaves model, compared to a 5 nM affinity variant; lowering affinity to 174 nM resulted in prolonged serum pharmacokinetics, but reduced brain and CSF exposure. The study demonstrates that binding affinity optimization of TfR-binding antibodies could improve their brain and CSF exposure even in the absence of monovalent TfR engagement.
Collapse
Affiliation(s)
- George Thom
- Antibody Discovery and Protein Engineering , MedImmune , Milstein Building, Granta Park, Cambridge CB21 6GH , U.K
| | - Matthew Burrell
- Antibody Discovery and Protein Engineering , MedImmune , Milstein Building, Granta Park, Cambridge CB21 6GH , U.K
| | - Arsalan S Haqqani
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Alvaro Yogi
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Etienne Lessard
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Eric Brunette
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Christie Delaney
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Ewa Baumann
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Deborah Callaghan
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| | - Natalia Rodrigo
- Antibody Discovery and Protein Engineering , MedImmune , Milstein Building, Granta Park, Cambridge CB21 6GH , U.K
| | - Carl I Webster
- Antibody Discovery and Protein Engineering , MedImmune , Milstein Building, Granta Park, Cambridge CB21 6GH , U.K
| | - Danica B Stanimirovic
- Human Health Therapeutics Portfolio , National Research Council of Canada , Ottawa , Ontario K1A0R6 , Canada
| |
Collapse
|
5
|
Callera GE, Antunes TT, He Y, Montezano AC, Yogi A, Savoia C, Touyz RM. c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II–Induced Hypertension. Hypertension 2016; 68:1179-1190. [DOI: 10.1161/hypertensionaha.116.07699] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2016] [Accepted: 08/11/2016] [Indexed: 12/14/2022]
Abstract
c-Src plays an important role in angiotensin II (Ang II) signaling. Whether this member of the Src family kinases is involved in the development of Ang II–induced hypertension and associated cardiovascular damage in vivo remains unknown. Here, we studied Ang II–infused (400 ng/kg/min) mice in which c-Src was partially deleted (
c-Src
+/−
) and in wild-type (WT,
c-Src
+/+
) mice treated with a c-Src inhibitor (CGP077675; 25 mg/kg/d). Ang II increased blood pressure and induced endothelial dysfunction in WT mice, responses that were ameliorated in
c-Src
+/−
and CGP077675-treated mice. Vascular wall thickness and cross-sectional area were similarly increased by Ang II in WT and
c-Src
+/−
mice. CGP077675 further increased cross-sectional area in hypertensive mice. Cardiac dysfunction (ejection fraction and fractional shortening) in Ang II–infused WT mice was normalized in
c-Src
+/−
mice. Increased oxidative stress (plasma thiobarbituric acid–reactive substances, hydrogen peroxide, and vascular superoxide generation) in Ang II–infused WT mice was attenuated in c-Src–deficient and CGP077675-treated mice. Hyperactivation of vascular c-Src, ERK1/2 (extracellular signal–regulated kinase 1/2), and JNK (c-Jun N-terminal kinase) in hypertensive mice was normalized in CGP077675-treated and
c-Src
+/−
mice. Vascular fibronectin was increased by Ang II in all groups and further augmented by CGP077675. Cardiac fibrosis and inflammation induced by Ang II were amplified in
c-Src
+/−
and CGP-treated mice. Our data indicate that although c-Src downregulation attenuates development of hypertension, improves endothelial and cardiac function, reduces oxidative stress, and normalizes vascular signaling, it has little beneficial effect on fibrosis. These findings suggest a divergent role for c-Src in Ang II–dependent hypertension, where c-Src may be more important in regulating redox-sensitive cardiac and vascular function than fibrosis and remodeling.
Collapse
Affiliation(s)
- Glaucia E. Callera
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Tayze T. Antunes
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Ying He
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Augusto C. Montezano
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Alvaro Yogi
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Carmine Savoia
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| | - Rhian M. Touyz
- From the Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ontario, Canada (G.E.C., T.T.A., Y.H., A.C.M., A.Y., R.M.T.); Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom (A.C.M., R.M.T.); and Clinical and Molecular Medicine Department, Cardiology Unit, Sapienza University of Rome, Rome, Italy (C.S.)
| |
Collapse
|
6
|
Antunes TT, Callera GE, He Y, Yogi A, Ryazanov AG, Ryazanova LV, Zhai A, Stewart DJ, Shrier A, Touyz RM. Transient Receptor Potential Melastatin 7 Cation Channel Kinase: New Player in Angiotensin II-Induced Hypertension. Hypertension 2016; 67:763-73. [PMID: 26928801 DOI: 10.1161/hypertensionaha.115.07021] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2015] [Accepted: 01/13/2016] [Indexed: 12/30/2022]
Abstract
Transient receptor potential melastatin 7 (TRPM7) is a bifunctional protein comprising a magnesium (Mg(2+))/cation channel and a kinase domain. We previously demonstrated that vasoactive agents regulate vascular TRPM7. Whether TRPM7 plays a role in the pathophysiology of hypertension and associated cardiovascular dysfunction is unknown. We studied TRPM7 kinase-deficient mice (TRPM7Δkinase; heterozygous for TRPM7 kinase) and wild-type (WT) mice infused with angiotensin II (Ang II; 400 ng/kg per minute, 4 weeks). TRPM7 kinase expression was lower in heart and aorta from TRPM7Δkinase versus WT mice, effects that were further reduced by Ang II infusion. Plasma Mg(2+) was lower in TRPM7Δkinase versus WT mice in basal and stimulated conditions. Ang II increased blood pressure in both strains with exaggerated responses in TRPM7Δkinase versus WT groups (P<0.05). Acetylcholine-induced vasorelaxation was reduced in Ang II-infused TRPM7Δkinase mice, an effect associated with Akt and endothelial nitric oxide synthase downregulation. Vascular cell adhesion molecule-1 expression was increased in Ang II-infused TRPM7 kinase-deficient mice. TRPM7 kinase targets, calpain, and annexin-1, were activated by Ang II in WT but not in TRPM7Δkinase mice. Echocardiographic and histopathologic analysis demonstrated cardiac hypertrophy and left ventricular dysfunction in Ang II-treated groups. In TRPM7 kinase-deficient mice, Ang II-induced cardiac functional and structural effects were amplified compared with WT counterparts. Our data demonstrate that in TRPM7Δkinase mice, Ang II-induced hypertension is exaggerated, cardiac remodeling and left ventricular dysfunction are amplified, and endothelial function is impaired. These processes are associated with hypomagnesemia, blunted TRPM7 kinase expression/signaling, endothelial nitric oxide synthase downregulation, and proinflammatory vascular responses. Our findings identify TRPM7 kinase as a novel player in Ang II-induced hypertension and associated vascular and target organ damage.
Collapse
Affiliation(s)
- Tayze T Antunes
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Glaucia E Callera
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Ying He
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Alvaro Yogi
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Alexey G Ryazanov
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Lillia V Ryazanova
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Alexander Zhai
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Duncan J Stewart
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Alvin Shrier
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.)
| | - Rhian M Touyz
- From the Kidney Research Centre (T.T.A., G.E.C., Y.H., A.Y., R.M.T.) and Sprott Centre for Stem Cell Research and Regenerative Medicine Program (A.Z., D.J.S.), Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada; Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ (A.G.R., L.V.R.); Department of Physiology and Groupe de Recherche Axé sur la Structure des Protéines, McGill University, Montreal, QC, Canada (A.S.); and BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (R.M.T.).
| |
Collapse
|
7
|
Webster CI, Caram-Salas N, Haqqani AS, Thom G, Brown L, Rennie K, Yogi A, Costain W, Brunette E, Stanimirovic DB. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1. FASEB J 2016; 30:1927-40. [PMID: 26839377 DOI: 10.1096/fj.201500078] [Citation(s) in RCA: 53] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2015] [Accepted: 01/22/2016] [Indexed: 12/13/2022]
Abstract
Receptor mediated transcytosis harnessing the cellular uptake and transport of natural ligands across the blood-brain barrier (BBB) has been identified as a means for antibody delivery to the CNS. In this study, we characterized bispecific antibodies in which a BBB-crossing antibody fragment FC5 was used as a BBB carrier. Cargo antibodies were either a high-affinity, selective antibody antagonist of the metabotropic glutamate receptor-1 (BBB-mGluR1), a widely abundant CNS target, or an IgG that does not bind the CNS target (BBB-NiP). Both BBB-NiP and BBB-mGluR1 demonstrated a similar 20-fold enhanced rate of transcytosis across an in vitro BBB model compared with mGluR1 IgG fused to a control antibody fragment. All 3 bispecific antibodies exhibited identical pharmacokinetics in vivo Comparative assessment of BBB-NiP and BBB-mGluR1 revealed that, whereas their serum pharmacokinetics and BBB penetration were identical, their central disposition (brain levels) and elimination (cerebrospinal fluid levels) were widely different, due to central target-mediated removal of the mGluR1-engaging antibody. Central mGluR1 target engagement after systemic administration was demonstrated by a dose-dependent inhibition of mGluR-1-mediated thermal hyperalgesia and by colocalization of the antibody with thalamic neurons involved in mGluR1-mediated pain processing. We demonstrate the feasibility of targeting central G-protein-coupled receptors using a BBB-crossing bispecific antibody approach and emerging principles that govern brain distribution and disposition of these antibodies. These data will be important for designing safe and selective CNS antibody therapeutics.-Webster, C. I., Caram-Salas, N., Haqqani, A. S., Thom, G., Brown, L., Rennie, K., Yogi, A., Costain, W., Brunette, E., Stanimirovic, D. B. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
Collapse
Affiliation(s)
- Carl I Webster
- Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom;
| | - Nadia Caram-Salas
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - Arsalan S Haqqani
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - George Thom
- Antibody Discovery and Protein Engineering, MedImmune, Cambridge, United Kingdom
| | - Lee Brown
- Translational Sciences, MedImmune, Cambridge, United Kingdom; and
| | - Kerry Rennie
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - Alvaro Yogi
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - Willard Costain
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - Eric Brunette
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| | - Danica B Stanimirovic
- Human Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, Ontario, Canada
| |
Collapse
|
8
|
Gonzaga NA, Callera GE, Yogi A, Mecawi AS, Antunes-Rodrigues J, Queiroz RH, Touyz RM, Tirapelli CR. Acute ethanol intake induces mitogen-activated protein kinase activation, platelet-derived growth factor receptor phosphorylation, and oxidative stress in resistance arteries. J Physiol Biochem 2014; 70:509-23. [PMID: 24733165 DOI: 10.1007/s13105-014-0331-6] [Citation(s) in RCA: 37] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2013] [Accepted: 03/10/2014] [Indexed: 12/16/2022]
Abstract
In the present study, we investigated the role of angiotensin type I (AT1) receptor in reactive oxygen species (ROS) generation and mitogen-activated protein kinases (MAPK) activation induced by acute ethanol intake in resistance arteries. We also evaluated the effect of ethanol on platelet-derived growth factor receptors (PDGF-R) phosphorylation and the role of this receptor on ROS generation by ethanol. Ethanol (1 g/kg; p.o. gavage) effects were assessed within 30 min in male Wistar rats. Acute ethanol intake did not alter angiotensin I or angiotensin II levels in the rat mesenteric arterial bed (MAB). Ethanol induced vascular oxidative stress, and this response was not prevented by losartan (10 mg/kg; p.o. gavage), a selective AT1 receptor antagonist. MAB from ethanol-treated rats displayed increased SAPK/JNK and PDGF-R phosphorylation, responses that were not prevented by losartan. The phosphorylation levels of protein kinase B (Akt) and eNOS were not affected by acute ethanol intake. MAB nitrate levels and the reactivity of this tissue to acetylcholine, phenylephrine, and sodium nitroprusside were not affected by ethanol intake. Ethanol did not alter plasma antioxidant capacity, the levels of reduced glutathione, or the activities of superoxide dismutase and catalase in the rat MAB. Short-term effects of ethanol (50 mmol/l) were evaluated in vascular smooth muscle cells (VSMC) isolated from rat MAB. Ethanol increased ROS generation, and this response was not affected by AG1296, a PDGF-R inhibitor, or losartan. Finally, ethanol did not alter MAPK or PDGF-R phosphorylation in cultured VSMC. Our study provides novel evidence that acute ethanol intake induces ROS generation, PDGF-R phosphorylation, and MAPK activation through AT(1)-independent mechanisms in resistance arteries in vivo. MAPK and PDGF-R play a role in vascular signaling and cardiovascular diseases and may contribute to the vascular pathobiology of ethanol.
Collapse
Affiliation(s)
- Natália A Gonzaga
- Departamento de Enfermagem Psiquiátrica e Ciências Humanas, Laboratório de Farmacologia, Escola de Enfermagem de Ribeirão Preto, USP, Ribeirão Preto, SP, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Correa J, Girardi A, Salles T, Boaro K, Loredo F, Yogi A, Callera G, Touyz R, Bendhack L, Krieger J. Molecular mechanisms associated to reversion of proteinuria by RAS antagonists in renovascular hypertensive rats (1088.4). FASEB J 2014. [DOI: 10.1096/fasebj.28.1_supplement.1088.4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- Jose Correa
- Biological Sciences Federal University of Manaus ManausBrazil
| | | | - Thiago Salles
- Heart Institute University of Sao Paulo Sao PauloBrazil
| | | | - Felipe Loredo
- Biological Sciences Federal University of Manaus ManausBrazil
| | - Alvaro Yogi
- Kidney Research Centre University of OttawaOttawaONCanada
| | | | - Rhian Touyz
- Kidney Research Centre University of OttawaOttawaONCanada
| | - Lusiane Bendhack
- Pharmaceutical SciencesUniversity of Sao Paulo RIBEIRAO PRETOBrazil
| | - Jose Krieger
- Heart Institute University of Sao Paulo Sao PauloBrazil
| |
Collapse
|
10
|
Yogi A, Callera GE, O'Connor S, Antunes TT, Valinsky W, Miquel P, Montezano ACI, Perraud AL, Schmitz C, Shrier A, Touyz RM. Aldosterone signaling through transient receptor potential melastatin 7 cation channel (TRPM7) and its α-kinase domain. Cell Signal 2013; 25:2163-75. [PMID: 23838006 DOI: 10.1016/j.cellsig.2013.07.002] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2013] [Accepted: 07/01/2013] [Indexed: 12/20/2022]
Abstract
We demonstrated a role for the Mg(2+) transporter TRPM7, a bifunctional protein with channel and α-kinase domains, in aldosterone signaling. Molecular mechanisms underlying this are elusive. Here we investigated the function of TRPM7 and its α-kinase domain on Mg(2+) and pro-inflammatory signaling by aldosterone. Kidney cells (HEK-293) expressing wild-type human TRPM7 (WThTRPM7) or constructs in which the α-kinase domain was deleted (ΔKinase) or rendered inactive with a point mutation in the ATP binding site of the α-kinase domain (K1648R) were studied. Aldosterone rapidly increased [Mg(2+)]i and stimulated NADPH oxidase-derived generation of reactive oxygen species (ROS) in WT hTRPM7 and TRPM7 kinase dead mutant cells. Translocation of annexin-1 and calpain-II and spectrin cleavage (calpain target) were increased by aldosterone in WT hTRPM7 cells but not in α-kinase-deficient cells. Aldosterone stimulated phosphorylation of MAP kinases and increased expression of pro-inflammatory mediators ICAM-1, Cox-2 and PAI-1 in Δkinase and K1648R cells, effects that were inhibited by eplerenone (mineralocorticoid receptor (MR) blocker). 2-APB, a TRPM7 channel inhibitor, abrogated aldosterone-induced Mg(2+) responses in WT hTRPM7 and mutant cells. In 2-APB-treated ΔKinase and K1648R cells, aldosterone-stimulated inflammatory responses were unchanged. These data indicate that aldosterone stimulates Mg(2+) influx and ROS production in a TRPM7-sensitive, kinase-insensitive manner, whereas activation of annexin-1 requires the TRPM7 kinase domain. Moreover TRPM7 α-kinase modulates inflammatory signaling by aldosterone in a TRPM7 channel/Mg(2+)-independent manner. Our findings identify novel mechanisms for non-genomic actions of aldosterone involving differential signaling through MR-activated TRPM7 channel and α-kinase.
Collapse
Affiliation(s)
- Alvaro Yogi
- Kidney Research Centre, Dept. of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Canada
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Noel S, Liberelle B, Yogi A, Moreno MJ, Bureau MN, Robitaille L, De Crescenzo G. A non-damaging chemical amination protocol for poly(ethylene terephthalate) – application to the design of functionalized compliant vascular grafts. J Mater Chem B 2013; 1:230-238. [DOI: 10.1039/c2tb00082b] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
12
|
Yogi A, Callera GE, Mecawi AS, Batalhão ME, Carnio EC, Antunes-Rodrigues J, Queiroz RH, Touyz RM, Tirapelli CR. Acute ethanol intake induces superoxide anion generation and mitogen-activated protein kinase phosphorylation in rat aorta: A role for angiotensin type 1 receptor. Toxicol Appl Pharmacol 2012; 264:470-8. [DOI: 10.1016/j.taap.2012.08.029] [Citation(s) in RCA: 48] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2012] [Revised: 08/20/2012] [Accepted: 08/21/2012] [Indexed: 01/14/2023]
|
13
|
Callera GE, Montezano A, Yogi A, Touyz RM. Abstract 510: Altered c-Src Activity by Aldosterone in Vascular Smooth Muscle Cells From SHR Involves PDGFR, C-terminal Src Kinase (Csk) and Csk-binding Protein (CBP). Hypertension 2012. [DOI: 10.1161/hyp.60.suppl_1.a510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
We previously demonstrated that non-genomic signaling by aldosterone through c-Src-dependent pathways is up-regulated in SHR vascular smooth muscle cells (VSMCs). In the present study we examined molecular mechanisms underlying aldosterone-mediated aberrant regulation of c-Src, by focusing on processes that control c-Src catalytic activation as well as recruitment of enzyme regulators in SHR VSMCs. Through intramolecular interactions, c-Src undergoes conformational changes that determine its activation state. The inactive conformation occurs when the phosphorylated Tyr527 binds to the SH2 domain of the kinase. In cultured VSMCs from WKY aldosterone (100 nM) induced c-Src Tyr527 phosphorylation (153.5 ± 13.6 %), whereas this response was blunted in SHR cells indicating the lack of the regulatory loop of the kinase. C-terminal Src kinase (Csk) is a cytosolic kinase that catalyzes c-Src Tyr527 phosphorylation. This kinase is recruited to the membrane by the phosphorylated form of its transmembrane adaptor protein Csk-binding protein (CBP), in order to regulate c-Src activity. Aldosterone-stimulated VSMCs from SHR displayed reduced Csk content in the membrane fractions and lower levels of CBP phosphorylation compared with cells from WKY. Phospho-caveolin-1 (Cav 1 Tyr14) serves as a docking protein for recruiting Csk to membrane microdomains for the negative regulation of c-Src. Aldosterone induced Cav-1 phosphorylation increase in cells from WKY with a reduced response in those from SHR (176.4 ± 18.0 vs 116.3 ± 8.2 %). PDGFR is a potent activator of c-Src catalytic activity through the phosphorylation of the Tyr216 in the SH2 domain of the kinase, which overrides the inhibitory action of the Tyr 527. Aldosterone induced an increase in phosphorylation of both PDGFR (186.6 ± 26.2 vs 281.9 ± 26.7 %) and c-Src Tyr216 (145 ± 10.1 vs 200 ± 22.2 %) in VSMCs from SHR versus WKY. These events were inhibited by the MR antagonist, eplerenone and the PDGFR inhibitor, AG1296. Our findings demonstrate that key regulators of c-Src activity, specifically PDGFR, Csk and CBP, are altered in SHR VSMCs. These data identify new targets of interest in cellular processes associated with aldosterone-mediated vascular hypertrophy in hypertension.
Collapse
Affiliation(s)
- Glaucia E Callera
- Kidney Rsch Cntr, Dept. of Medicine, Ottawa Hosp Rsch Institute, Univ of Ottawa, Ottawa, Canada
| | - Augusto Montezano
- Institute of Cardiovascular & Med Sciences, BHF Glasgow Cardiovascular Rsch Cntr Univ of Glasgow, Glasgow, United Kingdom
| | - Alvaro Yogi
- Kidney Rsch Cntr, Dept. of Medicine, Ottawa Hosp Rsch Institute, Univ of Ottawa, Ottawa, Canada
| | - Rhian M Touyz
- Institute of Cardiovascular & Med Sciences, BHF Glasgow Cardiovascular Rsch Cntr Univ of Glasgow, Glasgow, United Kingdom
| |
Collapse
|
14
|
Antunes TT, Yogi A, He Y, Callera GE, Montezano AC, Ryazanov AG, Ryazanova LV, Touyz RM. Abstract 218: TRPM7 Kinase - A Novel Signaling Pathway for Ang II-induced MAPK Activation in Vascular Smooth Muscle Cells. Hypertension 2012. [DOI: 10.1161/hyp.60.suppl_1.a218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Transient receptor potential melastatin 7 (TRPM7) cation channel is a unique protein, which regulates transmembrane magnesium (Mg2+) transport through its channel domain, and intracellular signaling through its kinase domain. We previously demonstrated that TRPM7, is expressed on vascular smooth muscle cells (VSMC), controls Mg2+ influx, and is regulated by angiotensin II (Ang II). Low Mg2+ levels are among the many factors leading to hypertension, where intracellular Mg2+ deficiency and TRPM7 downregulation is observed. Despite the advancement in the understanding of Mg2+ and TRPM7 biology, the role of TRPM7, and its kinase, in hypertension remains elusive. In this study, we investigated whether deletion of TRPM7 kinase domain alters Ang II-induced Mg2+ influx and signaling in VSMCs. Cultured VSMCs from mesenteric arteries obtained from heterozygous mice for the TRPM7 kinase deletion (+/-) and WT mice were used. Mg2+ influx was assessed by fluorescence microscopy. Activation of MAP kinases was evaluated by immunoblotting. Ang II (10-7M) increase in Mg2+ influx was similar in VSMC from both, WT and TRPM7+/- mice (2.5-fold; p<0.001). Ang II increased phosphorylation of JNK (10-fold), p38MAPK (4-fold) and ERK1/2 (6.4-fold) in VSMC from WT mice (p<0.001). Ang II-induced MAPK activation was blunted in TRPM7+/- VSMC. Moreover, Ang II treatment induced PDGF-R (2-fold) and Akt phosphorylation (3-fold) in VSMC from WT mice (p<0.05), an effect that was also blunted in TRPM+/- VSMC. Ang II induced SMAD2/3 activation in VSMC from WT (1.5-fold; p<0.05) and, with a greater extent, TRPM7+/- mice (3.5-fold; p<0.05). To understand whether the blunted effects of Ang II on intracellular signaling in VSMC from TRPM7+/- mice could be attributed to downregulation of Ang II receptors, AT1R and AT2R expression was assessed. No differences in receptor expression were observed between VSMC from WT and TRPM+/-. In conclusion, our findings identify that TRPM7 kinase domain is not necessary for Mg2+ influx, but it seems to be a novel and important player in Ang II-induced signaling in VSMCs.
Collapse
Affiliation(s)
| | | | - Ying He
- Ottawa Hosp Rsch Institute, Ottawa, Canada
| | | | | | | | | | - Rhian M Touyz
- Institute of Cardiovascular and Med Sciences, Glasgow, United Kingdom
| |
Collapse
|
15
|
Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, Fujita J, Uezato H, Murayama S. Treatment and prognosis of angiosarcoma of the scalp and face: a retrospective analysis of 48 patients. Br J Radiol 2012; 85:e1127-33. [PMID: 22806620 DOI: 10.1259/bjr/31655219] [Citation(s) in RCA: 68] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/20/2023] Open
Abstract
OBJECTIVE The objective of this study was to retrospectively analyse the treatment results of clinically localised angiosarcoma of the scalp and face. METHODS The records of 48 patients who were treated between 1987 and 2009 were reviewed. single modality or a combination of surgery, radiotherapy, chemotherapy and immunotherapy were administered. The median follow-up of all 48 patients was 13.7 months (range 2.5-105.9 months). RESULTS At the time of analysis, 45 of 48 patients (93.8%) had disease recurrences, and the lung was the most frequent site for recurrence (37 patients). In multivariate analysis, performance status (PS) and number of tumours were significant predictors of lung-metastasis-free (LMF) rate. For patients with multifocal tumours, chemotherapy use significantly decreased the LMF rate (p=0.0072). The 2-year actuarial overall survival (OS), progression-free survival and local control rates in all 48 patients were 22.1%, 10.7% and 46.3%, respectively. In multivariate analysis, PS, number of tumours, surgery and radiotherapy were significant prognostic factors for OS. Patients treated with both surgery and radiotherapy (2-year OS: 45.8%) had a significantly more favourable OS (p<0.0001) than patients treated with either surgery or radiotherapy (2-year OS: 11.1%) and patients treated with neither surgery nor radiotherapy (2-year OS: 0%). CONCLUSIONS Our results indicated that PS and number of tumours were significant predictors for developing lung metastases. Our results also indicated that PS, number of tumours, surgery use and radiotherapy use were independent prognostic factors for OS. Multimodal treatments including surgery and radiotherapy were effective in improving OS for patients with these tumours. Advances in knowledge Multimodal treatments including surgery and radiotherapy are effective in improving overall survival for patients with angiosarcoma of the scalp and face.
Collapse
Affiliation(s)
- K Ogawa
- Department of Radiology, University of the Ryukyus, Okinawa, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
16
|
Briones AM, Nguyen Dinh Cat A, Callera GE, Yogi A, Burger D, He Y, Corrêa JW, Gagnon AM, Gomez-Sanchez CE, Gomez-Sanchez EP, Sorisky A, Ooi TC, Ruzicka M, Burns KD, Touyz RM. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 2012; 59:1069-78. [PMID: 22493070 DOI: 10.1161/hypertensionaha.111.190223] [Citation(s) in RCA: 237] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
We reported aldosterone as a novel adipocyte-derived factor that regulates vascular function. We aimed to investigate molecular mechanisms, signaling pathways, and functional significance of adipocyte-derived aldosterone and to test whether adipocyte-derived aldosterone is increased in diabetes mellitus-associated obesity, which contributes to vascular dysfunction. Studies were performed in the 3T3-L1 adipocyte cell line and mature adipocytes isolated from human and mouse (C57BL/6J) adipose tissue. Mesenteric arteries with and without perivascular fat and mature adipocytes were obtained from obese diabetic db/db and control db/+ mice. Aldosterone synthase (CYP11B2; mRNA and protein) was detected in 3T3-L1 and mature adipocytes, which secrete aldosterone basally and in response to angiotensin II (Ang II). In 3T3-L1 adipocytes, Ang II stimulation increased aldosterone secretion and CYP11B2 expression. Ang II effects were blunted by an Ang II type 1 receptor antagonist (candesartan) and inhibitors of calcineurin (cyclosporine A and FK506) and nuclear factor of activated T-cells (VIVIT). FAD286 (aldosterone synthase inhibitor) blunted adipocyte differentiation. In candesartan-treated db/db mice (1 mg/kg per day, 4 weeks) increased plasma aldosterone, CYP11B2 expression, and aldosterone secretion were reduced. Acetylcholine-induced relaxation in db/db mesenteric arteries containing perivascular fat was improved by eplerenone (mineralocorticoid receptor antagonist) without effect in db/+ mice. Adipocytes possess aldosterone synthase and produce aldosterone in an Ang II/Ang II type 1 receptor/calcineurin/nuclear factor of activated T-cells-dependent manner. Functionally adipocyte-derived aldosterone regulates adipocyte differentiation and vascular function in an autocrine and paracrine manner, respectively. These novel findings identify adipocytes as a putative link between aldosterone and vascular dysfunction in diabetes mellitus-associated obesity.
Collapse
Affiliation(s)
- Ana M Briones
- Kidney Research Centre, Ottawa Hospital Research Institute, and Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Rocha JT, Hipólito UV, Callera GE, Yogi A, Neto Filho MDA, Bendhack LM, Touyz RM, Tirapelli CR. Ethanol induces vascular relaxation via redox-sensitive and nitric oxide-dependent pathways. Vascul Pharmacol 2011; 56:74-83. [PMID: 22155162 DOI: 10.1016/j.vph.2011.11.006] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Revised: 08/24/2011] [Accepted: 11/28/2011] [Indexed: 11/15/2022]
Abstract
We investigated the role of reactive oxygen species (ROS) and nitric oxide (NO) in ethanol-induced relaxation. Vascular reactivity experiments showed that ethanol (0.03-200 mmol/L) induced relaxation in endothelium-intact and denuded rat aortic rings isolated from male Wistar rats. Pre-incubation of intact or denuded rings with l-NAME (non selective NOS inhibitor, 100 μmol/L), 7-nitroindazole (selective nNOS inhibitor, 100 μmol/L), ODQ (selective inhibitor of guanylyl cyclase enzyme, 1 μmol/L), glibenclamide (selective blocker of ATP-sensitive K(+) channels, 3 μmol/L) and 4-aminopyridine (selective blocker of voltage-dependent K(+) channels, 4-AP, 1 mmol/L) reduced ethanol-induced relaxation. Similarly, tiron (superoxide anion (O(2)(-)) scavenger, 1 mmol/L) and catalase (hydrogen peroxide (H(2)O(2)) scavenger, 300 U/mL) reduced ethanol-induced relaxation to a similar extent in both endothelium-intact and denuded rings. Finally, prodifen (non-selective cytochrome P450 enzymes inhibitor, 10 μmol/L) and 4-methylpyrazole (selective alcohol dehydrogenase inhibitor, 10 μmol/L) reduced ethanol-induced relaxation. In cultured aortic vascular smooth muscle cells (VSMCs), ethanol stimulated generation of NO, which was significantly inhibited by l-NAME. In endothelial cells, flow cytometry studies showed that ethanol increased cytosolic Ca(2+) concentration ([Ca(2+)]c), O(2)(-) and cytosolic NO concentration ([NO]c). Tiron inhibited ethanol-induced increase in [Ca(2+)]c and [NO]c. The major new finding of this work is that ethanol induces relaxation via redox-sensitive and NO-cGMP-dependent pathways through direct effects on ROS production and NO signaling. These findings identify putative molecular mechanisms whereby ethanol, at pharmacological concentrations, influences vascular reactivity.
Collapse
MESH Headings
- Animals
- Aorta/drug effects
- Aorta/metabolism
- Cells, Cultured
- Cyclic GMP/metabolism
- Endothelial Cells/drug effects
- Endothelial Cells/metabolism
- Endothelium, Vascular/drug effects
- Endothelium, Vascular/metabolism
- Ethanol/pharmacology
- Male
- Muscle, Smooth, Vascular/drug effects
- Muscle, Smooth, Vascular/metabolism
- Myocytes, Smooth Muscle/drug effects
- Myocytes, Smooth Muscle/metabolism
- Nitric Oxide/metabolism
- Oxidation-Reduction
- Rats
- Rats, Wistar
- Reactive Oxygen Species/metabolism
- Signal Transduction/drug effects
- Vasodilation/drug effects
Collapse
Affiliation(s)
- Juliana T Rocha
- Department of Psychiatric Nursing and Human Sciences, Laboratory of Pharmacology, College of Nursing of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
18
|
Nguyen Dinh Cat A, Briones AM, Callera GE, Yogi A, He Y, Montezano AC, Touyz RM. Adipocyte-Derived Factors Regulate Vascular Smooth Muscle Cells Through Mineralocorticoid and Glucocorticoid Receptors. Hypertension 2011; 58:479-88. [DOI: 10.1161/hypertensionaha.110.168872] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Adipose tissue influences vascular function through adipocyte-derived factors, including components of the renin-angiotensin-aldosterone system. Molecular mechanisms underlying these phenomena are elusive. We investigated the role of adipocyte-derived factors on mitogen-activated protein kinases (MAPKs), proinflammatory status, apoptosis, and mitogenic signaling in vascular smooth muscle cells (VSMCs) and questioned whether these effects involve mineralocorticoid receptor (MR), glucocorticoid receptor (GR), and angiotensin II type 1 receptor (AT
1
R). Cultured mouse VSMCs were exposed to adipocyte-conditioned medium (ACM) from differentiated 3T3-L1 adipocytes. ACM induced phosphorylation of stress-activated protein kinase/c-Jun N-terminal kinase, p38MAPK, and extracellular signal–regulated kinase 1/2 and increased expression of proinflammatory and proliferative markers in VSMCs. Eplerenone (MR antagonist), mifepristone (GR antagonist), and candesartan (AT
1
R antagonist) inhibited ACM-induced effects on extracellular signal–regulated kinase 1/2, p38MAPK, and proliferating cell nuclear antigen, without influencing apoptosis (Bax, Bcl, and caspase 3). Stress-activated protein kinase/c-Jun N-terminal kinase phosphorylation was inhibited by mifepristone and candesartan but not by eplerenone. ACM-induced increase of fibronectin, vascular cell adhesion molecule 1, and plasminogen activator inhibitor 1 expression was blocked by MR and AT
1
R antagonism but not by GR inhibition. ACM has no effect on GR, MR, and AT
1
R expression. Our data show that adipocyte-derived factors influence MAPK signaling, leading to VSMC proinflammatory and profibrotic responses through distinct pathways. Although ACM stimulates p38MAPK and extracellular signal–regulated kinase 1/2 phosphorylation through MR, GR, and AT
1
R, activation of stress-activated protein kinase/c-Jun N-terminal kinase involves GR and AT
1
R. These findings suggest that adipocyte-derived factors regulate VSMC function through specific MAPKs linked to MR, GR, and AT
1
R, a posttranslational phenomenon, because ACM did not influence receptor expression. Such cross-talk between adipocytes and VSMCs may provide a potential molecular mechanism linking renin-angiotensin-aldosterone system, adipocytes, and vascular function.
Collapse
Affiliation(s)
- Aurelie Nguyen Dinh Cat
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Ana M. Briones
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Glaucia E. Callera
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Alvaro Yogi
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Ying He
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Augusto C. Montezano
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| | - Rhian M. Touyz
- From the Ottawa Hospital Research Institute/University of Ottawa, Ottawa, Ontario, Canada; Current address (A.M.B.): Dpto Farmacología y Terapéutica, Facultad de Medicina, Universidad Autonoma de Madrid, Madrid, Spain
| |
Collapse
|
19
|
Callera GE, Yogi A, Briones AM, Montezano AC, He Y, Tostes RC, Schiffrin EL, Touyz RM. Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR. Cardiovasc Res 2011; 91:720-31. [DOI: 10.1093/cvr/cvr131] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, Quinn MT, Salaices M, Touyz RM. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR. ACTA ACUST UNITED AC 2011; 5:137-53. [PMID: 21419746 DOI: 10.1016/j.jash.2011.02.001] [Citation(s) in RCA: 73] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2010] [Revised: 02/03/2011] [Accepted: 02/03/2011] [Indexed: 02/07/2023]
Abstract
The functional significance and regulation of NAD(P)H oxidase (Nox) isoforms by angiotensin II (Ang II) and endothelin-1 (ET-1) in vascular smooth muscle cells (VSMCs) from normotensive Wistar-Kyoto (WKY) and spontaneously hypertensive rats (SHR) was studied. Expression of Nox1, Nox2, and Nox4 (gene and protein) and NAD(P)H oxidase activity were increased in SHR. Basal NAD(P)H oxidase activity was blocked by GKT136901 (Nox1/4 inhibitor) and by Nox1 siRNA in WKY cells and by siNOX1 and siNOX2 in SHR. Whereas Ang II increased expression of all Noxes in WKY, only Nox1 was influenced in SHR. Ang II-induced NAD(P)H activity was inhibited by siNOX1 in WKY and by siNOX1 and siNOX2 in SHR. ET-1 upregulated Nox expression only in WKY and increased NAD(P)H oxidase activity, an effect inhibited by siNOX1 and siNOX2. Nox1 co-localized with Nox2 but not with Nox4, implicating association between Nox1 and Nox2 but not between Nox1 and Nox4. These data highlight the complexity of Nox biology in VSMCs, emphasising that more than one Nox member, alone or in association, may be involved in NAD(P)H oxidase-mediated •O(2)(-) production. Nox1 regulation by Ang II, but not by ET-1, may be important in •O(2)(-) formation in VSMCs from SHR.
Collapse
Affiliation(s)
- Ana M Briones
- Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ontario, Canada
| | | | | | | | | | | | | | | | | |
Collapse
|
21
|
Yogi A, Callera GE, Aranha AB, Antunes TT, Graham D, McBride M, Dominiczak A, Touyz RM. Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. Hypertension 2011; 57:809-18. [PMID: 21383307 DOI: 10.1161/hypertensionaha.110.162719] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
Sphingosine-1-phosphate (S1P), a multifunctional phospholipid, regulates vascular cell function. Whether S1P influences vascular inflammatory responses, particularly in hypertension, is unclear. We tested the hypothesis that S1P is a proinflammatory mediator signaling through receptor tyrosine kinase transactivation and that responses are amplified in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats (SHRSPs), a model in which we demonstrated Edg1 (S1P1 receptor) to be a candidate gene for salt-sensitive hypertension. Vascular smooth muscle cell from Wistar-Kyoto rats and SHRSPs were studied. S1P receptor subtypes, S1P1 and S1P2, were similarly expressed in Wistar-Kyoto rats and SHRSPs. S1P induced phosphorylation of epidermal growth factor receptor and platelet-derived growth factor and activation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase, with amplified effects in SHRSPs versus Wistar-Kyoto rats. Inhibition of epidermal growth factor receptor and platelet-derived growth factor (with AG1478 and AG1296, respectively) abolished S1P-induced phosphorylation of p38 mitogen-activated protein kinase and c-Jun N-terminal kinase in Wistar-Kyoto rats with variable effects in SHRSPs. Vascular smooth muscle cell inflammation was evaluated by expression of adhesion molecules and functional responses assessed by monocyte adhesion. S1P stimulated expression of intercellular adhesion molecule 1 and vascular cell adhesion protein 1 and promoted monocyte adhesion, particularly in SHRSP cells. S1P-mediated inflammation was blunted by AG1478 and AG1296 in SHRSP cells. VPC23019, a S1P1 receptor antagonist, inhibited S1P-induced mitogen-activated protein kinase phosphorylation, intercellular adhesion molecule 1 and vascular cell adhesion protein 1 expression, and monocyte adhesion. Our data indicate that molecular processes underlying vascular inflammation and cell adhesion in SHRSPs involve S1P/S1P1 receptors and phosphorylation of receptor tyrosine kinases. We identify a novel pathway linking S1P/S1P1 receptors to specific proinflammatory signaling pathways through epidermal growth factor receptor and platelet-derived growth factor transactivation, a process that is upregulated in SHRSPs. Such molecular events may contribute to vascular inflammation in hypertension.
Collapse
Affiliation(s)
- Alvaro Yogi
- Kidney Research Centre, University of Ottawa/Ottawa Hospital Research Institute, 451 Smyth Rd, Ottawa, Ontario KIH 8M5, Canada.
| | | | | | | | | | | | | | | |
Collapse
|
22
|
Yogi A, Callera GE, Antunes TT, Tostes RC, Touyz RM. Transient receptor potential melastatin 7 (TRPM7) cation channels, magnesium and the vascular system in hypertension. Circ J 2010; 75:237-45. [PMID: 21150127 DOI: 10.1253/circj.cj-10-1021] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Decreased Mg(2+) concentration has been implicated in altered vascular reactivity, endothelial dysfunction and structural remodeling, processes important in vascular changes and target organ damage associated with hypertension. Unlike our knowledge of other major cations, mechanisms regulating cellular Mg(2+) handling are poorly understood. Until recently little was known about protein transporters controlling transmembrane Mg(2+) influx. However, new research has uncovered a number of genes and proteins identified as transmembrane Mg(2+) transporters, particularly transient receptor potential melastatin (TRPM) cation channels, TRPM6 and TRPM7. Whereas TRPM6 is found primarily in epithelial cells, TRPM7 is ubiquitously expressed. Vascular TRPM7 has been implicated as a signaling kinase involved in vascular smooth muscle cell growth, apoptosis, adhesion, contraction, cytoskeletal organization and migration, and is modulated by vasoactive agents, pressure, stretch and osmotic changes. Emerging evidence suggests that vascular TRPM7 function might be altered in hypertension. The present review discusses the importance of Mg(2+) in vascular biology in hypertension and focuses on transport systems, mainly TRPM7, that might play a role in the control of vascular Mg(2+) homeostasis. Elucidation of the relationship between the complex systems responsible for regulation of Mg(2+) homeostasis, the role of TRPM7 in vascular signaling, and the cardiovascular impact will be important for understanding the clinical implications of hypomagnesemia in cardiovascular disease.
Collapse
Affiliation(s)
- Alvaro Yogi
- Kidney Research Center, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Canada
| | | | | | | | | |
Collapse
|
23
|
Yogi A, Callera GE, O'Connor SE, He Y, Tostes RC, Mazur A, Touyz RM. Magnesium supplementation attenuates aldosterone‐induced hypertension, kidney damage and oxidative stress in genetically hypomagnesemic mice. FASEB J 2010. [DOI: 10.1096/fasebj.24.1_supplement.917.21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | | | - Ying He
- University of OttawaOttawaONCanada
| | | | - Andrzej Mazur
- Institut National de la Recherche AgronomiqueSaint‐Genes‐ChampanelleFrance
| | | |
Collapse
|
24
|
de Andrade CR, Leite PF, Montezano AC, Casolari DA, Yogi A, Tostes RC, Haddad R, Eberlin MN, Laurindo FRM, de Souza HP, Corrêa FMA, de Oliveira AM. Increased endothelin-1 reactivity and endothelial dysfunction in carotid arteries from rats with hyperhomocysteinemia. Br J Pharmacol 2009; 157:568-80. [PMID: 19371338 DOI: 10.1111/j.1476-5381.2009.00165.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
BACKGROUND AND PURPOSE There are interactions between endothelin-1 (ET-1) and endothelial vascular injury in hyperhomocysteinemia (HHcy), but the underlying mechanisms are poorly understood. Here we evaluated the effects of HHcy on the endothelin system in rat carotid arteries. EXPERIMENTAL APPROACH Vascular reactivity to ET-1 and ET(A) and ET(B) receptor antagonists was assessed in rings of carotid arteries from normal rats and those with HHcy. ET(A) and ET(B) receptor expression was assessed by mRNA (RT-PCR), immunohistochemistry and binding of [(125)I]-ET-1. KEY RESULTS HHcy enhanced ET-1-induced contractions of carotid rings with intact endothelium. Selective antagonism of ET(A) or ET(B) receptors produced concentration-dependent rightward displacements of ET-1 concentration response curves. Antagonism of ET(A) but not of ET(B) receptors abolished enhancement in HHcy tissues. ET(A) and ET(B) receptor gene expressions were not up-regulated. ET(A) receptor expression in the arterial media was higher in HHcy arteries. Contractions to big ET-1 served as indicators of endothelin-converting enzyme activity, which was decreased by HHcy, without reduction of ET-1 levels. ET-1-induced Rho-kinase activity, calcium release and influx were increased by HHcy. Pre-treatment with indomethacin reversed enhanced responses to ET-1 in HHcy tissues, which were reduced also by a thromboxane A(2) receptor antagonist. Induced relaxation was reduced by BQ788, absent in endothelium-denuded arteries and was decreased in HHcy due to reduced bioavailability of NO. CONCLUSIONS AND IMPLICATIONS Increased ET(A) receptor density plays a fundamental role in endothelial injury induced by HHcy. ET-1 activation of ET(A) receptors in HHcy changed the balance between endothelium-derived relaxing and contracting factors, favouring enhanced contractility.
Collapse
Affiliation(s)
- C R de Andrade
- Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Yogi A, Callera GE, Tostes R, Touyz RM. Bradykinin regulates calpain and proinflammatory signaling through TRPM7-sensitive pathways in vascular smooth muscle cells. Am J Physiol Regul Integr Comp Physiol 2009; 296:R201-7. [DOI: 10.1152/ajpregu.90602.2008] [Citation(s) in RCA: 45] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Transient receptor potential melastatin-7 (TRPM7) channels have recently been identified to be regulated by vasoactive agents acting through G protein-coupled receptors in vascular smooth muscle cells (VSMC). However, downstream targets and functional responses remain unclear. We investigated the subcellular localization of TRPM7 in VSMCs and questioned the role of TRPM7 in proinflammatory signaling by bradykinin. VSMCs from Wistar-Kyoto rats were studied. Cell fractionation by sucrose gradient and differential centrifugation demonstrated that in bradykinin-stimulated cells, TRPM7 localized in fractions corresponding to caveolae. Immunofluorescence confocal microscopy revealed that TRPM7 distributes along the cell membrane, that it has a reticular-type intracellular distribution, and that it colocalizes with flotillin-2, a marker of lipid rafts. Bradykinin increased expression of calpain, a TRPM7 target, and stimulated its cytosol/membrane translocation, an effect blocked by 2-APB (TRPM7 inhibitor) and U-73122 (phospholipase C inhibitor), but not by chelerythrine (PKC inhibitor). Expression of proinflammatory mediators VCAM-1 and cyclooxygenase-2 (COX-2) was time-dependently increased by bradykinin. This effect was blocked by Hoe-140 (B2 receptor blocker) and 2-APB. Our data demonstrate that in bradykinin-stimulated VSMCs: 1) TRPM7 is upregulated, 2) TRPM7 associates with cholesterol-rich microdomains, and 3) calpain and proinflammatory mediators VCAM-1 and COX2 are regulated, in part, via TRPM7- and phospholipase C-dependent pathways through B2 receptors. These findings identify a novel signaling pathway for bradykinin, which involves TRPM7. Such phenomena may play a role in bradykinin/B2 receptor-mediated inflammatory responses in vascular cells.
Collapse
|
26
|
Paravicini TM, Yogi A, Mazur A, Touyz RM. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2008; 53:423-9. [PMID: 19103997 DOI: 10.1161/hypertensionaha.108.124651] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
Inadequate magnesium intake and hypomagnesemia may contribute to chronic diseases, such as hypertension. The novel magnesium transporter TRPM7 is a critical regulator of magnesium homeostasis in vascular cells, but its role in pathophysiology is unclear. In a model of hypomagnesemia, we examined microvascular structure and function, TRPM7 expression, and vascular inflammatory status using inbred mice selected for normal-high intracellular magnesium levels or low intracellular magnesium levels (MgLs). Blood pressure was significantly increased in MgLs compared with normal-high intracellular magnesium levels. Pressurized myography of mesenteric resistance arteries showed that MgLs had significantly impaired endothelial function together with decreased plasma nitrate levels and endothelial NO synthase expression when compared with normal-high intracellular magnesium levels. Significant differences in vascular structure were also evident in both mesenteric arteries and aortas from MgLs. Aortas from MgLs had increased medial cross-sectional areas, whereas mesenteric arteries from MgLs had increased lumen diameters with increased medial cross-sectional areas, indicating outward hypertrophic remodeling. Expression of the magnesium transporter TRPM7 was significantly elevated in the vasculature of MgLs, whereas expression of a TRPM7 downstream target, the anti-inflammatory molecule annexin-1, was reduced. MgLs had increased expression of vascular cell adhesion molecule-1 and plasminogen activator inhibitor-1, indicating vascular inflammation. Taken together, these data demonstrate that the inherited magnesium status of MgLs and normal-high intracellular magnesium levels mice affects magnesium transporter expression, endothelial function, vascular structure, and inflammation. Our findings suggest a potential regulatory role for TRPM7 signaling in the maintenance of vascular integrity. Alterations in magnesium status and/or TRPM7 signaling may contribute to vascular injury in conditions associated with hypomagnesemia.
Collapse
Affiliation(s)
- Tamara M Paravicini
- Kidney Research Centre, University of Ottawa/Ottawa Health Research Institute, 451 Smyth Rd, Ottawa, ON, KIH 8M5 Canada
| | | | | | | |
Collapse
|
27
|
Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RAS, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart. Circ Res 2008; 103:1319-26. [DOI: 10.1161/circresaha.108.184911] [Citation(s) in RCA: 183] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Angiotensin-converting enzyme 2 (ACE2) converts the vasopressor angiotensin II (Ang II) into angiotensin (1-7) [Ang(1-7)], a peptide reported to have vasodilatory and cardioprotective properties. Inactivation of the ACE2 gene in mice has been reported by one group to result in an accumulation of Ang II in the heart and an age-related defect in cardiac contractility. A second study confirmed the role of ACE2 as an Ang II clearance enzyme but failed to reproduce the contractility defects previously reported in ACE2-deficient mice. The reasons for these differences are unclear but could include differences in the accumulation of Ang II or the deficiencies in Ang(1-7) in the mouse models used. As a result, the roles of ACE2, Ang II, and Ang(1-7) in the heart remain controversial. Using a novel strategy, we targeted the chronic overproduction of either Ang II or Ang(1-7) in the heart of transgenic mice and tested their effect on age-related contractility and on cardiac remodeling in response to a hypertensive challenge. We demonstrate that a chronic accumulation of Ang II in the heart does not result in cardiac contractility defects, even in older (8-month-old) mice. Likewise, transgenic animals with an 8-fold increase in Ang(1-7) peptide in the heart exhibited no differences in resting blood pressure or cardiac contractility as compared to age-matched controls, but they had significantly less ventricular hypertrophy and fibrosis than their nontransgenic littermates in response to a hypertensive challenge. Analysis of downstream signaling cascades demonstrates that cardiac Ang(1-7) selectively modulates some of the downstream signaling effectors of cardiac remodeling. These results suggest that Ang(1-7) can reduce hypertension-induced cardiac remodeling through a direct effect on the heart and raise the possibility that pathologies associated with ACE2 inactivation are mediated in part by a decrease in production of Ang(1-7).
Collapse
Affiliation(s)
- Chantal Mercure
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Alvaro Yogi
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Glaucia E. Callera
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Anna B. Aranha
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Michael Bader
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Anderson J. Ferreira
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Robson A. S. Santos
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Thomas Walther
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Rhian M. Touyz
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| | - Timothy L. Reudelhuber
- From the Clinical Research Institute of Montreal (IRCM) (C.M., T.L.R.), Montreal, Canada; Kidney Research Center (A.Y., G.E.C., A.B.A., R.M.T.), University of Ottawa, Ottawa, Canada; Max-Delbrück Center for Molecular Medicine (M.B.), Berlin-Buch, Germany; Federal University of Minas Gerais (A.J.F., R.A.S.S.), Belo Horizonte, Brazil; Centre of Biomedical Research (T.W.), Hull York Medical School, University of Hull, UK
| |
Collapse
|
28
|
Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL, Touyz RM. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 2008; 28:1511-8. [PMID: 18467645 DOI: 10.1161/atvbaha.108.168021] [Citation(s) in RCA: 142] [Impact Index Per Article: 8.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVE Synergistic interactions between aldosterone (Aldo) and angiotensin II (Ang II) have been implicated in vascular inflammation, fibrosis, and remodeling. Molecular mechanisms underlying this are unclear. We tested the hypothesis that c-Src activation, through receptor tyrosine kinase transactivation, is critically involved in synergistic interactions between Aldo and Ang II and that it is upstream of promigratory signaling pathways in vascular smooth muscle cells (VSMCs). METHODS AND RESULTS VSMCs from WKY rats were studied. At low concentrations (10(-10) mol/L) Aldo and Ang II alone did not influence c-Src activation, whereas in combination they rapidly increased phosphorylation (P<0.01), an effect blocked by eplerenone (Aldo receptor antagonist) and irbesartan (AT1R blocker). This synergism was attenuated by AG1478 and AG1296 (inhibitors of EGFR and PDGFR, respectively), but not by AG1024 (IGFR inhibitor). Aldo and Ang II costimulation induced c-Src-dependent activation of NAD(P)H oxidase and c-Src-independent activation of ERK1/2 (P<0.05), without effect on ERK5, p38MAPK, or JNK. Aldo/Ang II synergistically activated RhoA/Rho kinase and VSMC migration, effects blocked by PP2, apocynin, and fasudil, inhibitors of c-Src, NADPH oxidase, and Rho kinase, respectively. CONCLUSIONS Aldo/Ang II synergistically activate c-Src, an immediate signaling response, through EGFR and PDGFR, but not IGFR transactivation. This is associated with activation of redox-regulated RhoA/Rho kinase, which controls VSMC migration. Although Aldo and Ang II interact to stimulate ERK1/2, such effects are c-Src-independent. These findings indicate differential signaling in Aldo-Ang II crosstalk and highlight the importance of c-Src in redox-sensitive RhoA, but not ERK1/2 signaling. Blockade of Aldo/Ang II may be therapeutically useful in vascular remodeling associated with abnormal VSMC migration.
Collapse
Affiliation(s)
- A C Montezano
- Ottawa Health Research Institute, University of Ottawa, 451 Smyth Road, Ottawa, K1H 8M5, Ontario, Canada
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Tirapelli CR, Leone AFC, Yogi A, Tostes RC, Lanchote VL, Uyemura SA, Resstel LBM, Corrêa FMA, Padovan CM, de Oliveira AM, Coelho EB. Ethanol consumption increases blood pressure and alters the responsiveness of the mesenteric vasculature in rats. J Pharm Pharmacol 2008; 60:331-41. [PMID: 18284813 DOI: 10.1211/jpp.60.3.0008] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Chronic ethanol consumption and hypertension are related. In the current study we investigated whether changes in reactivity of the mesenteric arterial bed could account for the increased blood pressure associated with chronic ethanol intake. Changes in reactivity to phenylephrine and acetylcholine were investigated in the perfused mesenteric bed from rats treated with ethanol for 2 or 6 weeks and their age-matched controls. Mild hypertension was observed in chronically ethanol-treated rats. Treatment of rats for 6 weeks induced an increase in the contractile response of endothelium-intact mesenteric bed to phenylephrine, but not denuded rat mesenteric bed. The phenylephrine-induced increase in perfusion pressure was not altered after 2 weeks' treatment with ethanol. Moreover, acetylcholine-induced endothelium-dependent relaxation was reduced by ethanol treatment for 6 weeks, but not 2 weeks. Pre-treatment with indometacin, a cyclooxygenase inhibitor, reduced the maximum effect induced by phenylephrine (Emax) in endothelium-intact mesenteric bed from both control and ethanol-treated rats. No differences in the Emax values for phenylephrine were observed between groups in the presence of indometacin. L-NNA, a nitric oxide (NO) synthase (NOS) inhibitor, increased the Emax for phenylephrine in endothelium-intact mesenteric bed from control rats but not from ethanol-treated rats. Levels of endothelial NOS (eNOS) mRNA were not altered by chronic ethanol consumption. However, chronic ethanol intake strongly reduced eNOS protein levels in the mesenteric bed. This study shows that chronic ethanol consumption increases blood pressure and alters the reactivity of the mesenteric bed. Moreover, the increased vascular response to phenylephrine observed in the mesenteric bed is maintained by two mechanisms: an increased release of endothelial-derived vasoconstrictor prostanoids and a reduced modulatory action of endothelial NO, which seems to be associated with reduced post-transcriptional expression of eNOS.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Psychiatric Nursing and Human Sciences, College of Nursing of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Yogi A, Mercure C, Touyz J, Callera GE, Montezano ACI, Aranha AB, Tostes RC, Reudelhuber T, Touyz RM. Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 2008; 51:500-6. [PMID: 18195161 DOI: 10.1161/hypertensionaha.107.103192] [Citation(s) in RCA: 64] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
We demonstrated previously that, in mice with chronic angiotensin II-dependent hypertension, gp91phox-containing NADPH oxidase is not involved in the development of high blood pressure, despite being important in redox signaling. Here we sought to determine whether a gp91phox homologue, Nox1, may be important in blood pressure elevation and activation of redox-sensitive pathways in a model in which the renin-angiotensin system is chronically upregulated. Nox1-deficient mice and transgenic mice expressing human renin (TTRhRen) were crossed, and 4 genotypes were generated: control, TTRhRen, Nox1-deficient, and TTRhRen Nox1-deficient. Blood pressure and oxidative stress (systemic and renal) were increased in TTRhRen mice (P<0.05). This was associated with increased NADPH oxidase activation. Nox1 deficiency had no effect on the development of hypertension in TTRhRen mice. Phosphorylation of c-Src, mitogen-activated protein kinases, and focal adhesion kinase was significantly increased 2- to 3-fold in kidneys from TTRhRen mice. Activation of c-Src, p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and focal adhesion kinase but not of extracellular signal regulated kinase 1/2 or extracellular signal regulated kinase 5, was reduced in TTRhRen/Nox1-deficient mice (P<0.05). Expression of procollagen III was increased in TTRhRen and TTRhRen/Nox1-deficient mice versus control mice, whereas vascular cell adhesion molecule-1 was only increased in TTRhRen mice. Our findings demonstrate that, in Nox1-deficient TTRhRen mice, blood pressure is elevated despite reduced NADPH oxidase activation, decreased oxidative stress, and attenuated redox signaling. Our results suggest that Nox1-containing NADPH oxidase plays a key role in the modulation of systemic and renal oxidative stress and redox-dependent signaling but not in the elevation of blood pressure in a model of chronic angiotensin II-dependent hypertension.
Collapse
Affiliation(s)
- Alvaro Yogi
- Kidney Research Centre, Ontario Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Tirapelli CR, Fukada SY, Yogi A, Chignalia AZ, Tostes RC, Bonaventura D, Lanchote VL, Cunha FQ, de Oliveira AM. Gender-specific vascular effects elicited by chronic ethanol consumption in rats: a role for inducible nitric oxide synthase. Br J Pharmacol 2007; 153:468-79. [PMID: 18037914 DOI: 10.1038/sj.bjp.0707589] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND AND PURPOSE Epidemiological data suggest that the risk of ethanol-associated cardiovascular disease is greater in men than in women. This study investigates the mechanisms underlying gender-specific vascular effects elicited by chronic ethanol consumption in rats. EXPERIMENTAL APPROACH Vascular reactivity experiments using standard muscle bath procedures were performed on isolated thoracic aortae from rats. mRNA and protein for inducible NO synthase (iNOS) and for endothelial NOS (eNOS) was assessed by RT-PCR or western blotting, respectively. KEY RESULTS In male rats, chronic ethanol consumption enhanced phenylephrine-induced contraction in both endothelium-intact and denuded aortic rings. However, in female rats, chronic ethanol consumption enhanced phenylephrine-induced contraction only in endothelium denuded aortic rings. After pre-incubation of endothelium-intact rings with L-NAME, both male and female ethanol-treated rats showed larger phenylephrine-induced contractions in aortic rings, compared to the control group. Acetylcholine-induced relaxation was not affected by ethanol consumption. The effects of ethanol on responses to phenylephrine were similar in ovariectomized (OVX) and intact (non-OVX) female rats. In the presence of aminoguanidine, but not 7-nitroindazole, the contractions to phenylephrine in rings from ethanol-treated female rats were greater than that found in control tissues in the presence of the inhibitors. mRNA levels for eNOS and iNOS were not altered by ethanol consumption. Ethanol intake reduced eNOS protein levels and increased iNOS protein levels in aorta from female rats. CONCLUSIONS AND IMPLICATIONS Gender differences in the vascular effects elicited by chronic ethanol consumption were not related to ovarian hormones but seemed to involve the upregulation of iNOS.
Collapse
Affiliation(s)
- C R Tirapelli
- Department of Psychiatry Nursing and Human Sciences, College of Nursing of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Yogi A, Callera GE, Montezano ACI, Aranha AB, Tostes RC, Schiffrin EL, Touyz RM. Endothelin-1, but not Ang II, activates MAP kinases through c-Src independent Ras-Raf dependent pathways in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007; 27:1960-7. [PMID: 17569879 DOI: 10.1161/atvbaha.107.146746] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
OBJECTIVE Endothelin-1 (ET-1) and angiotensin II (Ang II) activate common signaling pathways to promote changes in vascular reactivity, remodeling, inflammation, and oxidative stress. Here we sought to determine whether upstream regulators of mitogen-activated protein kinases (MAPKs) are differentially regulated by ET-1 and Ang II focusing on the role of c-Src and the small GTPase Ras. METHODS AND RESULTS Mesenteric vascular smooth muscle cells (VSMCs) from mice with different disruption levels in the c-Src gene (c-Src(+/-) and c-Src(-/-)) and wild-type (c-Src(+/+)) were used. ET-1 and Ang II induced extracellular signal-regulated kinase (ERK) 1/2, SAPK/JNK, and p38MAPK phosphorylation in c-Src(+/+) VSMCs. In VSMCs from c-Src(+/-) and c-Src(-/-), Ang II effects were blunted, whereas c-Src deficiency had no effect in ET-1-induced MAPK activation. Ang II but not ET-1 induced c-Src phosphorylation in c-Src(+/+) VSMCs. Activation of c-Raf, an effector of Ras, was significantly increased by ET-1 and Ang II in c-Src(+/+) VSMCs. Ang II but not ET-1-mediated c-Raf phosphorylation was inhibited by c-Src deficiency. Knockdown of Ras by siRNA inhibited both ET-1 and Ang II-induced MAPK phosphorylation. CONCLUSIONS Our data indicate differential regulation of MAPKs by distinct G protein-coupled receptors. Whereas Ang II has an obligatory need for c-Src, ET-1 mediates its actions through a c-Src-independent Ras-Raf-dependent pathway for MAPK activation. These findings suggest that Ang II and ET-1 can activate similar signaling pathways through unrelated mechanisms. MAP kinases are an important point of convergence for Ang II and ET-1.
Collapse
Affiliation(s)
- A Yogi
- Kidney Research Centre, University of Ottawa/Ottawa Health Research Institute, 451 Smyth Rd, Ottawa, ON, KIH 8M5
| | | | | | | | | | | | | |
Collapse
|
33
|
Callera GE, Montezano AC, Yogi A, Tostes RC, Touyz RM. Vascular signaling through cholesterol-rich domains: implications in hypertension. Curr Opin Nephrol Hypertens 2007; 16:90-104. [PMID: 17293683 DOI: 10.1097/mnh.0b013e328040bfbd] [Citation(s) in RCA: 37] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
PURPOSE OF REVIEW Lipid rafts are emerging as key players in the integration of cellular responses. Alterations in these highly regulated signaling cascades are important in structural, mechanical and functional abnormalities that underlie vascular pathological processes. The present review focuses on recent advances in signal transduction through caveolae/lipid rafts, implicated in hypertensive processes. RECENT FINDINGS Caveolae/lipid rafts function as sites of dynamic regulatory events in receptor-induced signal transduction. Mediators of vascular function, including G-protein coupled receptors, Src family tyrosine kinases, receptor tyrosine kinases, protein phosphatases and nitric oxide synthase, are concentrated within these microdomains. The assembly of functionally active nicotinamide adenine dinucleotide phosphate oxidase and subsequent reactive oxygen species production are also dependent on interactions within the caveolae/lipid rafts. Recent findings have also demonstrated the importance of actin-cytoskeleton and focal adhesion sites for protein interactions with caveolae/lipid raft. SUMMARY Many vascular signaling processes are altered in hypertension. Whether these events involve lipid rafts/caveolae remains unclear. A better understanding of how signaling molecules compartmentalize in lipid rafts/caveolae will provide further insights into molecular mechanisms underlying vascular damage in cardiovascular disease.
Collapse
Affiliation(s)
- Glaucia E Callera
- Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada.
| | | | | | | | | |
Collapse
|
34
|
Tirapelli CR, Casolari DA, Yogi A, Tostes RC, Legros E, Lanchote VL, Uyemura SA, de Oliveira AM. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery. Alcohol 2007; 41:77-85. [PMID: 17466482 DOI: 10.1016/j.alcohol.2007.02.004] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2006] [Revised: 01/16/2007] [Accepted: 02/09/2007] [Indexed: 12/27/2022]
Abstract
The purpose of the present work was to investigate whether conversion of exogenous applied big-endothelin-1 (Big-ET-1) as well as the basal release and mRNA levels of endothelin-1 (ET-1) is altered by ethanol consumption in the rat carotid. The measurement of the contraction induced by Big-ET-1 served as an indicative of functional endothelin (ET)-converting enzyme (ECE) activity. Cumulative application of exogenous Big-ET-1 elicited a concentration-related contraction with the concentration-response curve shifted to the right when compared to ET-1. In endothelium-intact rings, phosphoramidon (1 mmol/l), a nonselective ECE/neutral endopeptidase (NEP) inhibitor, produced a rightward displacement of the concentration-response curves and reduced the maximal contractile response to Big-ET-1. However, in endothelium-denuded rings phosphoramidon reduced the maximum contraction for Big-ET-1 but did not alter the potency when compared to the curves obtained in the absence of the inhibitor. Ethanol consumption for 2, 6, or 10 weeks reduced the contractile effect elicited by Big-ET-1 in carotid rings with intact endothelium when compared to control or isocaloric rings. However, no differences on Big-ET-1-induced contraction were observed after endothelial denudation. On the other hand, ethanol consumption increased ET-1-induced contraction. Finally, chronic ethanol consumption did not alter either the mRNA levels for pre-pro-ET-1 nor the basal release of ET-1. The present findings show that chronic ethanol consumption does not alter the mRNA levels for ET-1 or its basal release in the rat carotid. Moreover, ethanol intake reduces the contraction induced by exogenously applied Big-ET-1 in carotid rings with intact endothelium, a fact that might be the result of a reduced conversion of this peptide by ECE on its mature active peptide ET-1.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Psychiatry Nursing and Human Sciences, College of Nursing of Ribeirão Preto, University of São Paulo (USP), SP, Brazil
| | | | | | | | | | | | | | | |
Collapse
|
35
|
Callera GE, Tostes RC, Yogi A, Montezano ACI, Touyz RM. Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Lond) 2006; 110:243-53. [PMID: 16271043 DOI: 10.1042/cs20050307] [Citation(s) in RCA: 87] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
We have demonstrated recently [Callera, Touyz, Teixeira, Muscara, Carvalho, Fortes, Schiffrin and Tostes (2003) Hypertension 42, 811-817] that increased vascular oxidative stress in DOCA (deoxycorticosterone acetate)-salt rats is associated with activation of the ET (endothelin) system via ETA receptors. The exact source of ET-1-mediated oxidative stress remains unclear. The aim of the present study was to investigate whether ET-1 increases generation of ROS (reactive oxygen species) in DOCA-salt hypertension through NADPH-oxidase-dependent mechanisms. Xanthine oxidase, eNOS (endothelial nitric oxide synthase) and COX-2 (cyclo-oxygenase-2) were also examined as potential ET-1 sources of ROS as well as mitochondrial respiration. DOCA-salt and control UniNX (uninephrectomized) rats were treated with the ETA antagonist BMS182874 (40 mg.day(-1).kg(-1) of body weight) or vehicle. Plasma TBARS (thiobarbituric acid-reacting substances) were increased in DOCA-salt compared with UniNX rats. Activity of NADPH and xanthine oxidases in aorta, mesenteric arteries and heart was increased in DOCA-salt rats. BMS182874 decreased plasma TBARS levels without influencing NADPH and xanthine oxidase activities in DOCA-salt rats. Increased p22(phox) protein expression and increased p47(phox) membrane translocation in arteries from DOCA-salt by rats were not affected by BMS182874 treatment. Increased eNOS and COX-2 expression, also observed in aortas from DOCA-salt rats, was unaltered by BMS182874. Increased mitochondrial generation of ROS in DOCA-salt rats was normalized by BMS182874. ETA antagonism also increased the expression of mitochondrial MnSOD (manganese superoxide dismutase) in DOCA-salt rats. In conclusion, activation of NADPH oxidase does not seem to be the major source of oxidative stress induced by ET-1/ETA in DOCA-salt hypertension, which also appears to be independent of increased activation of xanthine oxidase or eNOS/COX-2 overexpression. Mitochondria may play a role in ET-1-driven oxidative stress, as evidenced by increased mitochondrial-derived ROS in this model of hypertension.
Collapse
Affiliation(s)
- Glaucia E Callera
- Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada.
| | | | | | | | | |
Collapse
|
36
|
Borgheresi RAMB, Leroy JMG, Yogi A, DosSantos RA, Breno MC, Tostes RC. Pharmacologic and molecular characterization of the vascular ETA receptor in the venomous snake Bothrops jararaca. Exp Biol Med (Maywood) 2006; 231:729-35. [PMID: 16740989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/09/2023] Open
Abstract
Endothelins (ETs) and sarafotoxins (SRTXs) are active isopeptides that have very similar structures and functions. All isoforms interact with two specific G-protein-coupled receptors, ET(A) and ET(B). To characterize functional vascular ET receptors in the poisonous snake, Bothrops jararaca, cumulative concentration-response curves to ETs and SRTXs were performed in isolated aortic rings, in the absence and presence of selective ET receptor antagonists. Vascular expression of ET receptor messenger RNA (mRNA) was evaluated by reverse transcriptase (RT) polymerase chain reaction (PCR) analysis, and a fragment of the ET(A) receptor was cloned and sequenced. In vivo, ET-1 induced a dose-dependent biphasic response on anesthetized B. jararaca snakes. In vitro, ET-1, SRTX-b, ET-3, SRTX-c, and IRL-1620 induced concentration-dependent vasoconstriction, with a potency order suggesting the presence of typical ET(A) receptors. BQ-123, a selective ET(A) antagonist, inhibited contractions induced by ET-1 and SRTX-b with expected negative log of the dissociation constant, K(B), (pK(B)) values for mixed ET(A)/ET(B) receptor populations. The nonselective ET(A)/ET(B) receptors antagonist, PD-142893, produced similar inhibition. The ET(B) antagonist, IRL-1038, potentiated contractile responses to SRTX-c. ET-1 and SRTX-c responses were also potentiated when aortic rings were pretreated with N(omega)-nitro-L-arginine methyl ester (L-NAME) plus indomethacin. Processing of the B. jararaca aortic first-strand complementary DNA, by RT-PCR with primers designed from the Gallus gallus ET(A) receptor sequence, enabled isolation, purification, cloning, and sequencing of a single band. The partial sequence of the B. jararaca ET(A) receptor showed a very high sequence similarity with ET(A) receptor sequences from chicken, rat, human, and Xenopus. In conclusion, vascular responses to SRTXs/ETs in the B. jararaca aorta are mediated predominantly, but not exclusively, by typical ET(A) receptors.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Aorta, Thoracic/drug effects
- Base Sequence
- Blood Pressure/drug effects
- Bothrops
- Conserved Sequence
- Crotalid Venoms/pharmacology
- DNA, Complementary/genetics
- Dose-Response Relationship, Drug
- Endothelin A Receptor Antagonists
- Female
- Infusions, Intravenous
- Male
- Molecular Sequence Data
- Muscle Contraction/drug effects
- Muscle, Smooth, Vascular/drug effects
- Perfusion
- RNA, Messenger/analysis
- Receptor, Endothelin A/agonists
- Receptor, Endothelin A/chemistry
- Receptor, Endothelin A/metabolism
- Sequence Homology, Amino Acid
- Sequence Homology, Nucleic Acid
- Vasoconstriction/drug effects
- Vasoconstrictor Agents/pharmacology
Collapse
Affiliation(s)
- Rosa A M B Borgheresi
- Laboratory of Pharmacology, Butantan Institute, Av. Vital 1500, 05503-900 Sao Paulo, Brazil.
| | | | | | | | | | | |
Collapse
|
37
|
Tirapelli CR, Casolari DA, Montezano AC, Yogi A, Tostes RC, Legros E, D'Orléans-Juste P, Lanchote VL, Uyemura SA, de Oliveira AM. Ethanol consumption enhances endothelin-1-induced contraction in the isolated rat carotid. J Pharmacol Exp Ther 2006; 318:819-27. [PMID: 16651399 DOI: 10.1124/jpet.106.103010] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022] Open
Abstract
We investigated the mechanisms involved in the enhancement of endothelin (ET)-1 vascular reactivity induced by ethanol consumption. Ethanol intake for 2, 6, and 10 weeks enhanced the ET-1-induced contractile response of endothelium-intact but not endothelium-denuded rat carotid rings independently of the treatment duration. Conversely, phenylephrine-induced contraction was not affected by ethanol intake. The contraction induced by IRL1620 [succinyl-(Glu(9),Ala(11,15))-ET-1-(8-21)], a selective ET(B) agonist, was increased after treatment with ethanol in endothelium-intact but not in endothelium-denuded carotid rings. Moreover, ET-1- and IRL1620-induced relaxation was reduced in endothelium-intact phenylephrine-precontracted rings from ethanol-treated rats. Acetylcholine-induced relaxation was not affected by ethanol treatment. N(G)-Nitro-l-arginine methyl ester, 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one, indomethacin, and tetraethylammonium reduced the relaxation induced by IRL1620 in carotid glands from control but not ethanol-treated rats. The mRNA levels for ET(A) and ET(B) receptors were not altered by ethanol consumption. However, ethanol treatment reduced the protein expression of ET(B) receptors. Furthermore, immunohistochemical assays showed reduced immunostaining for endothelial ET(B) receptors after treatment with ethanol. We conclude that ethanol consumption enhances ET-1-induced contraction in the rat carotid and that this response is not different among the three periods of treatment used in this study. Finally, the potentiation of ET-1-induced vascular reactivity is probably caused by reduced expression of relaxing endothelial ET(B) receptors.
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of Sao Paulo, Sao Paulo, Sao Paulo, Brazil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Tirapelli CR, Casolari DA, Yogi A, Montezano AC, Tostes RC, Legros E, D'Orléans-Juste P, de Oliveira AM. Functional characterization and expression of endothelin receptors in rat carotid artery: involvement of nitric oxide, a vasodilator prostanoid and the opening of K+ channels in ETB-induced relaxation. Br J Pharmacol 2005; 146:903-12. [PMID: 16151434 PMCID: PMC1751214 DOI: 10.1038/sj.bjp.0706388] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2005] [Revised: 05/05/2005] [Accepted: 08/05/2005] [Indexed: 11/09/2022] Open
Abstract
We aimed to functionally characterize endothelin (ET) receptors in the rat carotid artery. mRNA and protein expressions of both ETA and ETB receptors, evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and Western immunoblotting, were detected in carotid segments. Immunohistochemical assays showed that ETB receptors are expressed in the endothelium and smooth muscle cells, while ETA receptors are expressed only in the smooth muscle cells. In endothelium-denuded vessels, levels of ETB receptor mRNA were reduced. Vascular reactivity experiments, using standard muscle bath procedures, showed that ET-1 induces contraction in endothelium-intact and -denuded carotid rings in a concentration-dependent manner. Endothelial removal enhanced ET-1-induced contraction. BQ123 and BQ788, selective antagonists for ETA and ETB receptors, respectively, produced concentration-dependent rightward displacements of the ET-1 concentration-response curves. IRL1620, a selective agonist for ETB receptors, induced a slight vasoconstriction that was abolished by BQ788, but not affected by BQ123. IRL1620-induced contraction was augmented after endothelium removal. ET-1 concentration dependently relaxed phenylephrine-precontracted rings with intact endothelium. The relaxation was augmented in the presence of BQ123, reduced in the presence of BQ788 and completely abolished after endothelium removal. IRL1620 induced vasorelaxation that was abolished by BQ788 and endothelium removal, but not affected by BQ123. Preincubation of intact rings with N(G)-nitro-L-arginine methyl ester (L-NAME), 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), indomethacin or tetraethylammonium (TEA) reduced IRL1620-induced relaxation. The combination of L-NAME, indomethacin and TEA completely abolished IRL1620-induced relaxation while sulfaphenazole did not affect this response. 4-aminopyridine (4-AP), but not apamin, glibenclamide or charybdotoxin, reduced IRL1620-induced relaxation. The major finding of this work is that it firstly demonstrated functionally the existence of both ETA and ETB vasoconstrictor receptors located on the smooth muscle of rat carotid arteries and endothelial ETB receptors that mediated vasorelaxation via NO-cGMP pathway, vasodilator cyclooxygenase product(s) and the activation of voltage-dependent K+ channels.
Collapse
MESH Headings
- Animals
- Blotting, Western
- Carotid Arteries/drug effects
- Carotid Arteries/metabolism
- Carotid Arteries/physiology
- Endothelin A Receptor Antagonists
- Endothelin B Receptor Antagonists
- Endothelin-1/pharmacology
- Endothelins/pharmacology
- Endothelium, Vascular/physiology
- Endothelium-Dependent Relaxing Factors/physiology
- Gene Expression/drug effects
- Immunohistochemistry
- Male
- Nitric Oxide/physiology
- Oligopeptides/pharmacology
- Peptide Fragments/pharmacology
- Peptides, Cyclic/pharmacology
- Piperidines/pharmacology
- Potassium Channels/physiology
- RNA, Messenger/genetics
- RNA, Messenger/metabolism
- Rats
- Rats, Wistar
- Receptor, Endothelin A/genetics
- Receptor, Endothelin A/physiology
- Receptor, Endothelin B/genetics
- Receptor, Endothelin B/physiology
- Reverse Transcriptase Polymerase Chain Reaction/methods
- Vasodilation/drug effects
- Vasodilation/physiology
Collapse
Affiliation(s)
- Carlos R Tirapelli
- Department of Pharmacology, Faculty of Medicine of Ribeirão Preto, University of São Paulo (USP), SP, Brazil
| | - Debora A Casolari
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Alvaro Yogi
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Augusto C Montezano
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Rita C Tostes
- Department of Pharmacology, Institute of Biomedical Sciences, USP, São Paulo, SP, Brazil
| | - Eurode Legros
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Universite de Sherbrooke, QC, Canada
| | - Pedro D'Orléans-Juste
- Department of Pharmacology, Medical School, Institut de pharmacologie de Sherbrooke, Universite de Sherbrooke, QC, Canada
| | - Ana M de Oliveira
- Department of Physics and Chemistry, Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, USP, Ribeirão Preto, SP, Brazil
| |
Collapse
|
39
|
Callera GE, Montezano ACI, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM. c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats. Hypertension 2005; 46:1032-8. [PMID: 16157790 DOI: 10.1161/01.hyp.0000176588.51027.35] [Citation(s) in RCA: 82] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Aldosterone plays an important role in the pathogenesis of hypertension. We previously demonstrated that nongenomic signaling by aldosterone in vascular smooth muscle cells occurs through c-Src–dependent pathways. Here we tested the hypothesis that upregulation of c-Src by aldosterone plays a role in increased mitogen-activated protein (MAP) kinase activation, [
3
H]-proline incorporation, and NADPH-driven generation of reactive oxygen species, thereby inducing cell growth, collagen production, and inflammation, respectively, in vascular smooth muscle cells from spontaneously hypertensive rats. The time course of c-Src phosphorylation by aldosterone was shifted to the left in vascular myocytes from hypertensive animals. Aldosterone rapidly increased phosphorylation of p38 MAP kinase and extracellular signal–regulated kinase with significantly greater effects in cells from spontaneously hypertensive rats versus control cells (
P
<0.05). Aldosterone increased NADPH oxidase activity with significantly greater responses in vascular smooth muscle cells from hypertensive animals (
P
<0.05). These events were associated with enhanced [
3
H]proline incorporation (index of collagen synthesis) in cells from spontaneously hypertensive rats (
P
<0.05). The NADPH oxidase activity increase, collagen synthesis, c-Src, and MAP kinase phosphorylation induced by aldosterone were significantly reduced by eplerenone (selective mineralocorticoid receptor blocker) and PP2 (selective c-Src inhibitor). In conclusion, nongenomic signaling by exogenous aldosterone, mediated through c-Src, is increased in vascular smooth muscle cells from spontaneously hypertensive rats. Upregulation of c-Src signaling may be important in the profibrotic and proinflammatory actions of aldosterone in this genetic model of hypertension.
Collapse
Affiliation(s)
- Glaucia E Callera
- Ottawa Health Research Institute, University of Ottawa, Ottawa, Canada.
| | | | | | | | | | | | | |
Collapse
|
40
|
Tempone AG, Borborema SET, de Andrade HF, de Amorim Gualda NC, Yogi A, Carvalho CS, Bachiega D, Lupo FN, Bonotto SV, Fischer DCH. Antiprotozoal activity of Brazilian plant extracts from isoquinoline alkaloid-producing families. Phytomedicine 2005; 12:382-90. [PMID: 15957374 DOI: 10.1016/j.phymed.2003.10.007] [Citation(s) in RCA: 58] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Leishmaniasis and Chagas disease afflict the poorest countries in the world. The Brazilian flora represents a rich source for the screening of potential antiparasitic compounds. In this work, we tested the total alkaloid and ethanol extracts of nine different plants from Brazilian families which produce isoquinoline alkaloids, to determine their in vitro antiparasitic effect against L. chagasi and T. cruzi parasites. Promastigotes of L. chagasi were shown to be susceptible only to the total alkaloid extracts of A. crassiflora (EC50 value = 24.89 microg/ml), A. coriacea (EC50 value = 41.60 microg/ml), C. ovalifolia (EC50 value = 63.88 microg/ml) and G. australis (EC50 value = 37.88 microg/ml). Except for the G. australis total alkaloids, all the three extracts presented a considerable activity when tested against intracellular amastigotes. The most effective alkaloid extracts were those from A. crassiflora and C. ovalifolia, which reduced the number of infected macrophages at 25 microg/ml by 86.1% and 89.8%, respectively. Among the 18 tested extracts, 16 showed anti-Trypanosoma activity. Eight extracts (A. crassiflora, A. coriacea, C. ovalifolia, D. furfuracea, D. lanceolata, S. guianensis, X. emarginata and G. australis) were the most effective against the trypomastigotes, killing approximately 100% of the parasites at the maximal concentration of 100 microg/ml. Cytotoxicity against mammalian cells was evaluated for all extracts, but potential ones showed little or no cytotoxicity and a considerable antiparasitic effect, including D. furfuracea, D. lanceolata, G. australis, S. guianensis and X. emarginata. Plants are a rich source of natural compounds, and a powerful tool for the development of new arsenals for the therapy of protozoan diseases.
Collapse
Affiliation(s)
- A G Tempone
- Instituto de Ciências Biomédicas, Department Parasitologia, Universidade de São Paulo, Brasil
| | | | | | | | | | | | | | | | | | | |
Collapse
|
41
|
Abstract
Increasing evidence indicates that aldosterone elicits vascular effects through nongenomic signaling pathways. We tested the hypothesis that aldosterone induces activation of vascular mitogen-activated protein (MAP) kinases and NADPH oxidase via c-Src–dependent mechanisms in vascular smooth muscle cells (VSMCs). Aldosterone effects on activation of c-Src, p38MAP kinase, and NADPH oxidase, and incorporation of [
3
H]proline, an index of collagen synthesis, were assessed in cultured rat VSMCs. Studies were performed in the absence and presence of eplerenone, a selective mineralocorticoid receptor blocker, PP2, a selective Src inhibitor, and SB212190, a selective p38MAPK inhibitor. Phosphorylation of c-Src was dose-dependently increased by aldosterone, with maximal responses obtained at 10
−7
mol/L. Aldosterone increased p38MAP kinase phosphorylation, NAD(P)H oxidase activation, and [
3
H]proline incorporation. These responses were abrogated by eplerenone and almost abolished by PP2. Aldosterone-stimulated incorporation of [
3
H]proline was significantly reduced by SB212190, indicating that p38MAP kinase plays a role in profibrotic actions of aldosterone. To unambiguously demonstrate the importance of aldosterone in c-Src signaling, VSMCs from c-Src
+/+
and c-Src
+/−
mice were also studied. Aldosterone increased phosphorylation of c-Src, p38MAP kinase, and cortactin, a Src-specific substrate, in c-Src
+/+
VSMCs, but not in c-Src-deficient cells. Taken together, our findings demonstrate that nongenomic signaling by aldosterone occurs through c-Src–dependent pathways. These processes may play an important role in profibrotic actions of aldosterone.
Collapse
Affiliation(s)
- Glaucia E Callera
- CIHR Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Canada.
| | | | | | | | | | | | | |
Collapse
|
42
|
Touyz RM, Mercure C, He Y, Javeshghani D, Yao G, Callera GE, Yogi A, Lochard N, Reudelhuber TL. Angiotensin II-Dependent Chronic Hypertension and Cardiac Hypertrophy Are Unaffected by gp91phox-Containing NADPH Oxidase. Hypertension 2005; 45:530-7. [PMID: 15753233 DOI: 10.1161/01.hyp.0000158845.49943.5e] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
The gp91phox-containing NADPH oxidase is the major source of reactive oxygen species (ROS) in the cardiovascular system and inactivation of gp91phox has been reported to blunt hypertension and cardiac hypertrophy seen in angiotensin (Ang) II-infused animals. In the current study, we sought to determine the role of gp91phox-derived ROS on cardiovascular outcomes of chronic exposure to Ang II. The gp91phox-deficient mice were crossed with transgenic mice expressing active human renin in the liver (TTRhRen). TTRhRen mice exhibit chronic Ang II–dependent hypertension and frank cardiac hypertrophy by age 10 to 12 weeks. Four genotypes of mice were generated: control, TTRhRen trangenics (TTRhRen), gp91phox-deficient (gp91
−
), and TTRhRen transgenic gp91phox-deficient (TTRhRen/gp91
−
). Eight to 10 mice/group were studied. ROS levels were significantly reduced (
P
<0.05) in the heart and aorta of TTRhRen/gp91
−
and gp91
−
mice compared with control counterparts, and this was associated with reduced cardiac, aortic, and renal NADPH oxidase activity (
P
<0.05). Systolic blood pressure (SBP), cardiac mass, and cardiac fibrosis were increased in TTRhRen versus controls. In contrast to its action on ROS generation, gp91phox inactivation had no effect on development of hypertension or cardiac hypertrophy in TTRhRen mice, although interstitial fibrosis was reduced. Cardiac and renal expression of gp91phox homologues, Nox1 and Nox4, was not different between groups. Thus, although eliminating gp91phox-associated ROS production may be important in cardiovascular consequences in acute insult models, it does not prevent the development of hypertension and cardiac hypertrophy in a model in which the endogenous renin-angiotensin system is chronically upregulated.
Collapse
Affiliation(s)
- Rhian M Touyz
- CIHR Multidisciplinary Research Group on Hypertension, Clinical Research Institute of Montreal, University of Montreal, Quebec, Canada.
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Fischer DCH, de Amorim Gualda NC, Bachiega D, Carvalho CS, Lupo FN, Bonotto SV, Alves MDO, Yogi A, Santi SMD, Avila PE, Kirchgatter K, Moreno PRH. In vitro screening for antiplasmodial activity of isoquinoline alkaloids from Brazilian plant species. Acta Trop 2004; 92:261-6. [PMID: 15533296 DOI: 10.1016/j.actatropica.2004.08.009] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2003] [Revised: 07/12/2004] [Accepted: 08/17/2004] [Indexed: 11/19/2022]
Abstract
In the search for new antimalarial agents, nine Brazilian plant species were selected, from the Annonaceae (6), Menispermaceae (2) and Siparunaceae (1) families naturally occurring at the cerrado and Atlantic rainforest regions, in order to investigate their in vitro antiplasmodial activity. The ethanol and the alkaloid extracts were tested against K1, chloroquine-resistant, and Palo Alto, chloroquine-sensitive, strains of Plasmodium falciparum. The majority of the alkaloid extracts were more active than the ethanol ones, with IC(50) ranging 0.3-8.2 microg/mL. The crude Guatteria australis alkaloids were the most active against K1 with an IC(50) = 0.3 microg/mL. The most promising total alkaloid fractions for further bioguided isolation are those with the IC(50) < or = 5 microg/mL: G. australis, Cissampelos ovalifolia and Duguetia lanceolata.
Collapse
Affiliation(s)
- Dominique Corinne Hermine Fischer
- Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Av. Prof. Lineu Prestes 580, Bloco15, 05580-900, São Paulo, SP, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Callera GE, Yogi A, Tostes RC, Rossoni LV, Bendhack LM. Ca2+-Activated K+ Channels Underlying the Impaired Acetylcholine-Induced Vasodilation in 2K-1C Hypertensive Rats. J Pharmacol Exp Ther 2004; 309:1036-42. [PMID: 14978190 DOI: 10.1124/jpet.103.062810] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
We tested the hypothesis that an abnormal function of K(+) channels in vascular smooth muscle cells plays a key role in the impaired acetylcholine (ACh) vasodilation in aortas from two kidney-one clip (2K-1C) hypertensive rats and further investigated the K(+) channel subtype involved in this altered response. ACh-induced endothelium-dependent relaxation was assessed in aortic rings from 2K-1C and normotensive two kidney (2K) rats. Glibenclamide, an ATP-sensitive K(+) channel blocker, did not inhibit ACh-induced relaxation in aortic rings from 2K or 2K-1C rats. The voltage-dependent K(+) channels inhibitor 4-aminopyridine attenuated ACh-induced relaxation in both groups. Charybdotoxin and iberiotoxin, blockers of Ca(2+)-sensitive (K(Ca)) and large-conductance K(Ca) (BK(Ca)) channels, respectively, reduced ACh-induced relaxation in aortic rings from 2K rats without affecting this response in those from 2K-1C rats, abolishing the differences between groups. ACh-induced relaxation in vessels from both 2K and 2K-1C rats was unaffected by apamin, a small-conductance K(Ca) blocker. NS1619 [1,3-dihydro-1-[2-hydroxy-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-2H-benzimidazol-2-one], an activator of K(Ca), induced a smaller vasodilation in endothelium-denuded aortic rings from 2K-1C rats compared with those from 2K rats. Iberiotoxin reduced sodium nitroprusside-induced relaxation in endothelium-denuded aortic rings from 2K without affecting this response in those from 2K-1C rats. The inhibition of Na(+),K(+)-ATPase with ouabain had no effects on ACh-induced relaxation in aortic rings from 2K-1C or 2K rats. These data indicate that a deficient functional activity of BK(Ca) channels plays a key role in the impaired ACh vasodilation in aortas from 2K-1C rats.
Collapse
Affiliation(s)
- Glaucia E Callera
- Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, Av. Lineu Prestes, 1524 São Paulo, SP 05508-900 Brazil.
| | | | | | | | | |
Collapse
|
45
|
Yogi A, Callera GE, Tostes RCA, Rossoni LV. CONTRIBUTION OF ENDOTHELIN-1 TO HYPERTENSION AND TO CHANGES IN VASCULAR REACTIVITY TO PHENYLEPHRINE IN RATS AFTER CHRONIC TREATMENT WITH OUABAIN. J Hypertens 2004. [DOI: 10.1097/00004872-200402001-00113] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
|